甲状旁腺切除术可治愈未经药物治疗而未能抑制的继发性甲状旁腺功能亢进的血液透析患者中普遍存在的躯体化障碍。

The high prevalence of alexithymia in hemodialyzed patients with secondary hyperparathyroidism unsuppressed by medical therapy is cured by parathyroidectomy.

机构信息

Italian Institute Philosophical Studies, Naples, Italy.

出版信息

J Ren Nutr. 2010 Sep;20(5 Suppl):S64-70. doi: 10.1053/j.jrn.2010.06.004.

Abstract

There are scanty data available on alexithymia in patients with end-stage renal disease, which point to an independent association with depression and social support. This study was devised to investigate the prevalence of alexithymia and sleep disorders in patients maintenance hemodialysis with insuppressible secondary hyperparathyroidism, who need parathyroidectomy (PTX), because previous data from our laboratories as well as those of others showed that this patient-group are the worst sleepers among hemodialysis patients with end-stage renal disease. A total of 40 patients needing PTX were enrolled and studied before the surgery. As for the control group, 80 patients on maintenance hemodialysis not needing PTX were enrolled. We measured alexithymia with the Toronto Alexithymia Score (TAS-20), sleep disorders with the Pittsburgh Sleep Quality Index (PSQI), and depression with Beck Depression Inventory (BDI), intact parathyroid hormone (iPTH), calcium, phosphate, use of antihypertensives, systolic and diastolic blood pressure, hemoglobin concentration, and albumin concentration. Patients needing PTX in comparison with those not needing PTX had significantly higher iPTH, calcium, and phosphate; they also had significantly higher systolic and diastolic blood pressure. They were more significantly alexithymic (P < .001), had more severe sleep disorders (P < .001), and were more depressed (P < .043). In multivariate analysis, BDI correlated significantly with iPTH concentration (r = 0.505, P < .001). A reduction of TAS-20 occurred after PTX which correlated with the number of patients on antihypertensive drugs, PSQI, BDI, hemoglobin concentration in the univariate and multivariate analysis. When TAS-20 and PSQI were adjusted for BDI (using analysis of variance) there was still a significant difference of TAS-20 and PSQI between patients needing PTX and not needing PTX (P < .001). This study confirms the high prevalence of sleep disorders in patients with unsuppressed secondary hyperparathyroidism and discloses a high prevalence of Alexithymia which is ameliorated by PTX. However, the correlation of Alexithymia with sleep disorders does not depend on depression.

摘要

关于终末期肾病患者的述情障碍,仅有少量数据可用,这些数据表明述情障碍与抑郁和社会支持独立相关。本研究旨在调查维持性血液透析伴不可抑制的继发性甲状旁腺功能亢进症患者(需要甲状旁腺切除术(PTX))中述情障碍和睡眠障碍的患病率,因为我们实验室以及其他实验室的先前数据表明,与终末期肾病的血液透析患者相比,这群患者的睡眠质量最差。共有 40 名需要 PTX 的患者在手术前入组并进行了研究。作为对照组,招募了 80 名不需要 PTX 的维持性血液透析患者。我们使用多伦多述情障碍量表(TAS-20)测量述情障碍,使用匹兹堡睡眠质量指数(PSQI)测量睡眠障碍,使用贝克抑郁量表(BDI)测量抑郁,使用完整甲状旁腺激素(iPTH)、钙、磷、使用抗高血压药物、收缩压和舒张压、血红蛋白浓度和白蛋白浓度。与不需要 PTX 的患者相比,需要 PTX 的患者的 iPTH、钙和磷明显更高;他们的收缩压和舒张压也明显更高。他们的述情障碍明显更严重(P <.001),睡眠障碍更严重(P <.001),抑郁程度更高(P <.043)。在多变量分析中,BDI 与 iPTH 浓度显著相关(r = 0.505,P <.001)。PTX 后 TAS-20 降低,与多变量分析中的抗高血压药物数量、PSQI、BDI、血红蛋白浓度呈正相关。当 TAS-20 和 PSQI 用 BDI 进行调整(使用方差分析)时,仍有需要 PTX 的患者和不需要 PTX 的患者之间 TAS-20 和 PSQI 存在显著差异(P <.001)。这项研究证实了未被抑制的继发性甲状旁腺功能亢进症患者睡眠障碍的高患病率,并揭示了述情障碍的高患病率,PTX 可改善述情障碍。然而,述情障碍与睡眠障碍的相关性并不依赖于抑郁。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索